Testing effectiveness (Phase 2)UnknownNCT00363090
What this trial is testing
Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma
Who this might be right for
Lymphoma
Toronto Sunnybrook Regional Cancer Centre 84